| |
| Trade Name | LADARVISION 4000 EXCIMER LASER SYSTEM |
| Classification Name | excimer laser system |
| Generic Name | ophthalmic excimer laser system |
| Applicant | ALCON LABORATORIES,INC |
| PMA Number | P970043 |
| Supplement Number | S020 |
| Date Received | 05/27/2005 |
| Decision Date | 05/01/2006 |
| Product Code | |
| Docket Number | 06M-0323 |
| Notice Date | 08/17/2006 |
| Advisory Committee |
Ophthalmic |
| Supplement Type | panel track |
| Supplement Reason | labeling change - indications |
| Expedited Review Granted? | No |
| Combination Product |
No
|
| Information About: |
Labeling, Approval Order, Summary of Safety and Effectiveness |
Approval Order Statement Approval for the ladarvision 4000 excimer laser system and the ladar 6000 excimer laser system. These devices use a 6. 5 mm optical zone and a 9. 0 treatment zone and are indicated for wave-front guided customcornea laser assisted in-situ keratomileusis (lasik): 1) for the reduction or elimination of hyperopia and hyperopic astigmatism of +0. 75 d to less that +5. 00 d of sphere with up to -3. 00 d of cylinder (which has a magnitude less than or equal to the sphere in minus cylinder convention) and up to +5. 00 cycloplegic spherical equivalent at the spectacle plane; 2) in patients 21 years of age or older; and 3) in patients with documented stability of refraction for the prior 12 months, as demonstrated by a change in sphere and cylinder of less than or equal to 0. 50 d. |
| Approval Order |
Approval Order
|